Showing 8401-8410 of 8647 results for "".
- Innovative “Pay It Forward” Training Program for Specialty Eye Surgeonshttps://modernod.com/news/innovative-pay-it-forward-training-program-for-specialty-eye-surgeons/2479905/The Refractive Surgery Alliance (RSA) announced the creation of a new and innovative training program for vision correction surgeons. The RSA program structure is unique and recognizes the expanding and rapidly evolving field refractive surgery. Instead of training surgeons under a single
- Gaming for an Independent Life: Hope for Visually Impaired Children with New Computer Gamehttps://modernod.com/news/gaming-for-an-independent-life-hope-for-visually-impaired-children-with-new-computer-game/2479909/A new computer game, which developers say could help visually-impaired children lead independent lives, has been rolled out online and it is being made freely available for families, schools, and healthcare providers. The browser-based game, called Ey
- UK Calls on Drugmakers to Stockpile 6-Week Supply of Medicines to Cope With “No Deal” Brexithttps://modernod.com/news/uk-calls-on-drugmakers-to-stockpile-6-week-supply-of-medicines-to-cope-with-no-deal-brexit/2479911/The UK’s Department of Health and Social Care has asked pharmaceutical companies that supply drugs to NHS patients to “ensure they have a minimum of six weeks additional supply” of medicines, over and above their usual buffer stocks, in case imports from the EU are disrupted in
- Devices to Expand Role of Surgery in Glaucoma Treatmenthttps://modernod.com/news/devices-to-expand-role-of-surgery-in-glaucoma-treatment/2479914/The glaucoma surgical device market is expected to grow at a rate of nearly 23 percent over the next 5 years, according to a Market Scope report. The market is expected to grow to nearly $1.7 billion by 2023, up from a small base of just under $634 million in 2018. Minimally invasive glauc
- ProtoKinetix Enters into 3rd Phase of Retinal Cell Replacement Therapy Testing at UBChttps://modernod.com/news/protokinetix-enters-into-3rd-phase-of-retinal-cell-replacement-therapy-testing-at-ubc/2479918/ProtoKinetix has entered into the 3rd phase of testing in retinal cell replacement therapy at the University of British Columbia. Due to the positive results from the first two phases of testing where the AAGP-treated cells showed a dramatic increase in survivability versus untreated cells over a
- Lenstec Completes Enrollment of FDA Trial for SBL-3 IOLhttps://modernod.com/news/lenstec-completes-enrollment-of-fda-trial-for-sbl-3-iol/2479919/Lenstec announced that it has completed enrollment of the FDA trial for the SBL-3 IOL. The Lenstec SBL-3 IOL (segmented bifocal lens) is a non-concentric asymmetric multifocal refractive IOL that provides patients with superior near, intermediate, and distance vision. It also improves contrast se
- Staying Fit Might Cut Glaucoma Riskhttps://modernod.com/news/staying-fit-might-cut-glaucoma-risk/2479921/Meeting physical activity guidelines and being physically fit may reduce the risk of developing glaucoma by 40 percent to 50 percent, recent research suggests, according to a Reuters
- Joseph Gordon Named US President of Bausch + Lombhttps://modernod.com/news/joseph-gordon-named-us-president-of-bausch-lomb/2479922/Bausch + Lomb announced that Joseph Gordon has been named US president, Bausch + Lomb. In this role, Mr. Gordon will oversee the fully integrated U.S. eye care business, inclusive of all four business units – Vision Care, Consumer Health, Surgical, and Pharmaceuticals. He will report direct
- Penn’s Experimental Gene Therapy Saves Night Vision in Dogs, Paving the Way for Human Testshttps://modernod.com/news/penns-experimental-gene-therapy-saves-night-vision-in-dogs-paving-the-way-for-human-tests/2479925/In 1990, scientists discovered a genetic mutation that turns an important light-sensing protein in the retina into a toxin that steadily destroys the ability to see in low light. <
- University of Toledo Chemists Discover How Blue Light Speeds Blindnesshttps://modernod.com/news/university-of-toledo-chemists-discover-how-blue-light-speeds-blindness/2479929/Blue light from digital devices and the sun transforms vital molecules in the retina into cell killers, according to optical chemistry research at The University of Toledo. The process outlined in the study, which was recently published in the journal